成纤维细胞生长因子受体-话题@MedSci

#成纤维细胞生长因子受体#

5篇内容 | 753人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1709431, encodeId=5c771e09431c0, content=<a href='/topic/show?id=97be540642a' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子受体#</a>, objectTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , objectType=article, longId=200106, objectId=c2aa200106d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2aa200106d4, replyNumber=0, likeNumber=42, createdTime=2020-10-23, rootId=0, userName=ms5353107019656438, userId=d54031685112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2aa200106d4, moduleTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2aa200106d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1709430, encodeId=11e61e0943022, content=<a href='/topic/show?id=97be540642a' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子受体#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=41, createdTime=2020-10-10, rootId=0, userName=ms5353107019656438, userId=d54031685112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1709429, encodeId=a7b51e0942905, content=<a href='/topic/show?id=97be540642a' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子受体#</a>, objectTitle=成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查, objectType=article, longId=184090, objectId=d0cc1840903e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0cc1840903e, replyNumber=0, likeNumber=36, createdTime=2020-10-19, rootId=0, userName=ms5353107019656438, userId=d54031685112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0cc1840903e, moduleTitle=成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0cc1840903e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1709428, encodeId=a9d41e0942831, content=<a href='/topic/show?id=97be540642a' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子受体#</a>, objectTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, objectType=article, longId=163899, objectId=93891638993f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93891638993f, replyNumber=0, likeNumber=39, createdTime=2019-04-19, rootId=0, userName=ms5353107019656438, userId=d54031685112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93891638993f, moduleTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93891638993f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1709427, encodeId=81461e0942729, content=<a href='/topic/show?id=97be540642a' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子受体#</a>, objectTitle=J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症, objectType=article, longId=146933, objectId=2e12146933de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e12146933de, replyNumber=0, likeNumber=43, createdTime=2019-05-04, rootId=0, userName=ms5353107019656438, userId=d54031685112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e12146933de, moduleTitle=J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e12146933de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

成纤维细胞生长因子受体

2020-05-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#成纤维细胞生长因子受体#

Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关

2020-10-23

ms5353107019656438 (审核中...)

前往app查看评论内容

#成纤维细胞生长因子受体#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2020-10-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#成纤维细胞生长因子受体#

成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查

2020-10-19

ms5353107019656438 (审核中...)

前往app查看评论内容

#成纤维细胞生长因子受体#

成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定

2019-04-19

ms5353107019656438 (审核中...)

前往app查看评论内容

#成纤维细胞生长因子受体#

J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症

2019-05-04

科室
- - 订阅+
  - 更多科室
工具
服务